Filing Details
- Accession Number:
- 0001232524-10-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-19 20:12:10
- Reporting Period:
- 2010-11-18
- Filing Date:
- 2010-11-19
- Accepted Time:
- 2010-11-19 20:12:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Inc | JAZZ | Pharmaceutical Preparations (2834) | 050563787 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397268 | Lt Janne Wissel | C/O Jazz Pharmaceuticals, Inc. 3180 Porter Drive Palo Alto CA 94304 | Svp, Chief Regulatory Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-18 | 46,663 | $1.25 | 152,493 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-18 | 46,663 | $15.05 | 105,830 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2010-11-18 | 46,663 | $0.00 | 46,663 | $1.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 33,337 | 2019-01-20 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.35, inclusive.
- The reporting person undertakes to provide to Jazz Pharmaceuticals, Inc., any security holder of Jazz Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The options represented are vesting over three years measured from the vesting commencement date, January 21, 2009, with 1/3rd vesting on the first anniversary of the vesting commencment date and the remainder vesting in 24 equal monthly installments thereafter. On 11/18/2010, the Transaction Date, options representing 46,663 shares were excercisable.
Billionaire Hedge Funds
